Cargando…

How IGF-1 activates its receptor

The type I insulin-like growth factor receptor (IGF1R) is involved in growth and survival of normal and neoplastic cells. A ligand-dependent conformational change is thought to regulate IGF1R activity, but the nature of this change is unclear. We point out an underappreciated dimer in the crystal st...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavran, Jennifer M, McCabe, Jacqueline M, Byrne, Patrick O, Connacher, Mary Katherine, Wang, Zhihong, Ramek, Alexander, Sarabipour, Sarvenaz, Shan, Yibing, Shaw, David E, Hristova, Kalina, Cole, Philip A, Leahy, Daniel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381924/
https://www.ncbi.nlm.nih.gov/pubmed/25255214
http://dx.doi.org/10.7554/eLife.03772
_version_ 1782364533208121344
author Kavran, Jennifer M
McCabe, Jacqueline M
Byrne, Patrick O
Connacher, Mary Katherine
Wang, Zhihong
Ramek, Alexander
Sarabipour, Sarvenaz
Shan, Yibing
Shaw, David E
Hristova, Kalina
Cole, Philip A
Leahy, Daniel J
author_facet Kavran, Jennifer M
McCabe, Jacqueline M
Byrne, Patrick O
Connacher, Mary Katherine
Wang, Zhihong
Ramek, Alexander
Sarabipour, Sarvenaz
Shan, Yibing
Shaw, David E
Hristova, Kalina
Cole, Philip A
Leahy, Daniel J
author_sort Kavran, Jennifer M
collection PubMed
description The type I insulin-like growth factor receptor (IGF1R) is involved in growth and survival of normal and neoplastic cells. A ligand-dependent conformational change is thought to regulate IGF1R activity, but the nature of this change is unclear. We point out an underappreciated dimer in the crystal structure of the related Insulin Receptor (IR) with Insulin bound that allows direct comparison with unliganded IR and suggests a mechanism by which ligand regulates IR/IGF1R activity. We test this mechanism in a series of biochemical and biophysical assays and find the IGF1R ectodomain maintains an autoinhibited state in which the TMs are held apart. Ligand binding releases this constraint, allowing TM association and unleashing an intrinsic propensity of the intracellular regions to autophosphorylate. Enzymatic studies of full-length and kinase-containing fragments show phosphorylated IGF1R is fully active independent of ligand and the extracellular-TM regions. The key step triggered by ligand binding is thus autophosphorylation. DOI: http://dx.doi.org/10.7554/eLife.03772.001
format Online
Article
Text
id pubmed-4381924
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-43819242015-04-03 How IGF-1 activates its receptor Kavran, Jennifer M McCabe, Jacqueline M Byrne, Patrick O Connacher, Mary Katherine Wang, Zhihong Ramek, Alexander Sarabipour, Sarvenaz Shan, Yibing Shaw, David E Hristova, Kalina Cole, Philip A Leahy, Daniel J eLife Biochemistry The type I insulin-like growth factor receptor (IGF1R) is involved in growth and survival of normal and neoplastic cells. A ligand-dependent conformational change is thought to regulate IGF1R activity, but the nature of this change is unclear. We point out an underappreciated dimer in the crystal structure of the related Insulin Receptor (IR) with Insulin bound that allows direct comparison with unliganded IR and suggests a mechanism by which ligand regulates IR/IGF1R activity. We test this mechanism in a series of biochemical and biophysical assays and find the IGF1R ectodomain maintains an autoinhibited state in which the TMs are held apart. Ligand binding releases this constraint, allowing TM association and unleashing an intrinsic propensity of the intracellular regions to autophosphorylate. Enzymatic studies of full-length and kinase-containing fragments show phosphorylated IGF1R is fully active independent of ligand and the extracellular-TM regions. The key step triggered by ligand binding is thus autophosphorylation. DOI: http://dx.doi.org/10.7554/eLife.03772.001 eLife Sciences Publications, Ltd 2014-09-25 /pmc/articles/PMC4381924/ /pubmed/25255214 http://dx.doi.org/10.7554/eLife.03772 Text en Copyright © 2014, Kavran et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Biochemistry
Kavran, Jennifer M
McCabe, Jacqueline M
Byrne, Patrick O
Connacher, Mary Katherine
Wang, Zhihong
Ramek, Alexander
Sarabipour, Sarvenaz
Shan, Yibing
Shaw, David E
Hristova, Kalina
Cole, Philip A
Leahy, Daniel J
How IGF-1 activates its receptor
title How IGF-1 activates its receptor
title_full How IGF-1 activates its receptor
title_fullStr How IGF-1 activates its receptor
title_full_unstemmed How IGF-1 activates its receptor
title_short How IGF-1 activates its receptor
title_sort how igf-1 activates its receptor
topic Biochemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381924/
https://www.ncbi.nlm.nih.gov/pubmed/25255214
http://dx.doi.org/10.7554/eLife.03772
work_keys_str_mv AT kavranjenniferm howigf1activatesitsreceptor
AT mccabejacquelinem howigf1activatesitsreceptor
AT byrnepatricko howigf1activatesitsreceptor
AT connachermarykatherine howigf1activatesitsreceptor
AT wangzhihong howigf1activatesitsreceptor
AT ramekalexander howigf1activatesitsreceptor
AT sarabipoursarvenaz howigf1activatesitsreceptor
AT shanyibing howigf1activatesitsreceptor
AT shawdavide howigf1activatesitsreceptor
AT hristovakalina howigf1activatesitsreceptor
AT colephilipa howigf1activatesitsreceptor
AT leahydanielj howigf1activatesitsreceptor